Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.8500 (-0.91%) ($21.5400 - $22.1800) on Fri. Jun. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.17% (three month average) | RSI | 43 | Latest Price | $21.8500(-0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.085% in a week (0% probabilities). VXX(-34%) TLT(-12%) UNG(-6%) IFRA(-5%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.085% (StdDev 4.17%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
1 - 5 Day Possible Target | $16.04(-26.59%) | Resistance Level | $22.87 | 5 Day Moving Average | $22.07(-1%) | 10 Day Moving Average | $22.53(-3.02%) | 20 Day Moving Average | $22.87(-4.46%) | To recent high | -46.8% | To recent low | 0% | Market Cap | $1.624b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |